These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32886190)

  • 1. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
    Winther SA; Henriksen P; Vogt JK; Hansen TH; Ahonen L; Suvitaival T; Hein Zobel E; Frimodt-Møller M; Hansen TW; Hansen T; Parving HH; Legido-Quigley C; Rossing P; Pedersen O
    Diabetologia; 2020 Dec; 63(12):2713-2724. PubMed ID: 32886190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
    Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS
    Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiomics signatures of type 1 diabetes with and without albuminuria.
    Clos-Garcia M; Ahluwalia TS; Winther SA; Henriksen P; Ali M; Fan Y; Stankevic E; Lyu L; Vogt JK; Hansen T; Legido-Quigley C; Rossing P; Pedersen O
    Front Endocrinol (Lausanne); 2022; 13():1015557. PubMed ID: 36531462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin.
    Huo L; Li H; Zhu M; Liu Y; Ren L; Hu J; Wang X
    Front Endocrinol (Lausanne); 2023; 14():1257457. PubMed ID: 38075058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition.
    Koopen AM; de Clercq NC; Warmbrunn MV; Herrema H; Davids M; de Groot PF; Kootte RS; Bouter KEC; Nieuwdorp M; Groen AK; Prodan A
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32752028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota mediate melatonin signalling in association with type 2 diabetes.
    Huang X; Qiu Y; Gao Y; Zhou R; Hu Q; He Z; Lv Y; Wang X; Chen W; Deng Y; An Z; Zhang H; Mo Z; Lin R
    Diabetologia; 2022 Oct; 65(10):1627-1641. PubMed ID: 35768541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant intestinal microbiota in individuals with prediabetes.
    Allin KH; Tremaroli V; Caesar R; Jensen BAH; Damgaard MTF; Bahl MI; Licht TR; Hansen TH; Nielsen T; Dantoft TM; Linneberg A; Jørgensen T; Vestergaard H; Kristiansen K; Franks PW; ; Hansen T; Bäckhed F; Pedersen O
    Diabetologia; 2018 Apr; 61(4):810-820. PubMed ID: 29379988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADA.
    Luo S; Yue T; Liu Z; Yang D; Xu M; Ding Y; Jiang W; Xu W; Yan J; Weng J; Zheng X
    Front Endocrinol (Lausanne); 2022; 13():938358. PubMed ID: 36246882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
    Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
    Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated 16S rRNA Gene Sequencing and LC-MS Analysis Revealed the Interplay Between Gut Microbiota and Plasma Metabolites in Rats With Ischemic Stroke.
    Wu W; Sun Y; Luo N; Cheng C; Jiang C; Yu Q; Cheng S; Ge J
    J Mol Neurosci; 2021 Oct; 71(10):2095-2106. PubMed ID: 33954858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes.
    Li J; Morrow C; Barnes S; Wilson L; Womack ED; McLain A; Yarar-Fisher C
    Arch Phys Med Rehabil; 2022 Apr; 103(4):702-710. PubMed ID: 34126067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
    Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.
    Leiva-Gea I; Sánchez-Alcoholado L; Martín-Tejedor B; Castellano-Castillo D; Moreno-Indias I; Urda-Cardona A; Tinahones FJ; Fernández-García JC; Queipo-Ortuño MI
    Diabetes Care; 2018 Nov; 41(11):2385-2395. PubMed ID: 30224347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria.
    Saleem T; Dahpy M; Ezzat G; Abdelrahman G; Abdel-Aziz E; Farghaly R
    Appl Biochem Biotechnol; 2019 Jul; 188(3):854-867. PubMed ID: 30706418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.
    Zhou H; Zhao X; Sun L; Liu Y; Lv Y; Gang X; Wang G
    Dis Markers; 2020; 2020():3936247. PubMed ID: 32908614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connection Between BMI-Related Plasma Metabolite Profile and Gut Microbiota.
    Ottosson F; Brunkwall L; Ericson U; Nilsson PM; Almgren P; Fernandez C; Melander O; Orho-Melander M
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1491-1501. PubMed ID: 29409054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Kawasaki R; Ohashi Y; Akanuma Y; Yamada N; Sone H; Yamashita H; Katayama S;
    Diabetes Care; 2013 Sep; 36(9):2803-9. PubMed ID: 23620478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.